MabVax Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A

MabVax Therapeutics General Information

Description

MabVax Therapeutics Holdings Inc is a development-stage biopharmaceutical company works to discover, develop, and commercialize small molecule drugs to treat cancer-related illnesses. The company has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been vaccinated against targeted cancers with theie proprietary vaccines. Its pipeline include Therapeutic(MVT-5873), Radioimmunotherapy(MVT-1075), HuMab-Tn and others.

Contact Information

Website
www.mabvax.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11535 Sorrento Valley Road
  • Suite 400
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 11535 Sorrento Valley Road
  • Suite 400
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MabVax Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Merger/Acquisition 08-May-2018 Completed Generating Revenue
16. PIPE 22-Aug-2017 Completed Generating Revenue
15. PIPE 22-May-2017 Completed Generating Revenue
14. Debt - General 19-Jan-2016 Completed Generating Revenue
13. PIPE 01-Oct-2015 Completed Generating Revenue
12. PIPE 10-Apr-2015 Completed Generating Revenue
11. Reverse Merger 08-Jul-2014 Completed Generating Revenue
10. Later Stage VC (Series C1) 01-Jul-2014 Completed Generating Revenue
9. Later Stage VC (Series C) 13-Feb-2014 $12.1M $25.9M Completed Generating Revenue
8. Grant 01-Jan-2014 $400K $13.8M Completed Generating Revenue
To view MabVax Therapeutics’s complete valuation and funding history, request access »

MabVax Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
MabVax Therapeutics Holdings Inc is a development-stage biopharmaceutical company works to discover, develop, and commer
Drug Discovery
San Diego, CA
6 As of 2018

Plymouth Meeting, PA
 

Wilmington, DE
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MabVax Therapeutics Competitors (82)

One of MabVax Therapeutics’s 82 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Ayala Pharmaceuticals Corporation Wilmington, DE
Marengo Therapeutics Venture Capital-Backed Cambridge, MA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Iovance Biotherapeutics Corporation San Carlos, CA
You’re viewing 5 of 82 competitors. Get the full list »

MabVax Therapeutics Patents

MabVax Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11707522-B2 Human antibodies to tn antigen Active 13-Oct-2017
US-20190111164-A1 Human antibodies to tn antigen Active 13-Oct-2017
WO-2015187811-A2 Human monoclonal antibodies to ganglioside gd2 Inactive 04-Jun-2014
WO-2015187811-A3 Human monoclonal antibodies to ganglioside gd2 Inactive 04-Jun-2014
JP-2019047821-A Nucleic acids encoding human antibodies to sialyl-lewis a Active 26-Aug-2013 C07K16/2896
To view MabVax Therapeutics’s complete patent history, request access »

MabVax Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MabVax Therapeutics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biomark Capital PE/Buyout Minority
Burrill & Co Merchant Banking Firm Minority
Numoda Capital Innovations Venture Capital Minority
OPKO Health Corporation Minority
Solving Kids Cancer Foundation Corporation
You’re viewing 5 of 6 investors. Get the full list »

MabVax Therapeutics Acquisitions (1)

MabVax Therapeutics’s most recent deal was a Merger/Acquisition with Telik. The deal was made on 09-Jul-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Telik 09-Jul-2014 Merger/Acquisition Drug Discovery
To view MabVax Therapeutics’s complete acquisitions history, request access »

MabVax Therapeutics FAQs

  • When was MabVax Therapeutics founded?

    MabVax Therapeutics was founded in 2006.

  • Where is MabVax Therapeutics headquartered?

    MabVax Therapeutics is headquartered in San Diego, CA.

  • What is the size of MabVax Therapeutics?

    MabVax Therapeutics has 6 total employees.

  • What industry is MabVax Therapeutics in?

    MabVax Therapeutics’s primary industry is Drug Discovery.

  • Is MabVax Therapeutics a private or public company?

    MabVax Therapeutics is a Private company.

  • What is MabVax Therapeutics’s current revenue?

    The current revenue for MabVax Therapeutics is .

  • How much funding has MabVax Therapeutics raised over time?

    MabVax Therapeutics has raised $61.2M.

  • Who are MabVax Therapeutics’s investors?

    Biomark Capital, Burrill & Co, Numoda Capital Innovations, OPKO Health, and Solving Kids Cancer Foundation are 5 of 6 investors who have invested in MabVax Therapeutics.

  • Who are MabVax Therapeutics’s competitors?

    Inovio Pharmaceuticals, Ayala Pharmaceuticals, Marengo Therapeutics, Adaptimmune Therapeutics, and Iovance Biotherapeutics are some of the 82 competitors of MabVax Therapeutics.

  • When was MabVax Therapeutics acquired?

    MabVax Therapeutics was acquired on 08-May-2018.

  • Who acquired MabVax Therapeutics?

    MabVax Therapeutics was acquired by BioNTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process